Etiology
Tilleul P,
Brignone M,
Hassani Y,
Labrande C,
Pedeboscq S,
Gensollen S,
Lahille B,
Exinger D,
Bertholle V,
Billard M,
Charlety D,
Prebay D,
Pinguet F,
Taillibert S,
Cartalat S,
Chinot O,
Borget I;
Temozolomide Study Group of Société Française de Pharmacie Oncologique
Pharmacoepidemiol Drug Saf
2012 Aug;21(8):828-34.
Epub 2012 Mar 15
doi: 10.1002/pds.3233.
PMID: 22419509
Kizilarslanoglu MC,
Aksoy S,
Yildirim NO,
Ararat E,
Sahin I,
Altundag K
J BUON
2011 Jul-Sep;16(3):547-50.
PMID: 22006764
Chamberlain MC,
Johnston S
J Neurooncol
2009 Feb;91(3):359-67.
Epub 2008 Oct 25
doi: 10.1007/s11060-008-9722-2.
PMID: 18953491
Chamberlain MC,
Wei-Tsao DD,
Blumenthal DT,
Glantz MJ
Cancer
2008 May 1;112(9):2038-45.
doi: 10.1002/cncr.23404.
PMID: 18361434
Chamberlain MC,
Tsao-Wei DD,
Groshen S
Cancer
2006 Jan 1;106(1):172-9.
doi: 10.1002/cncr.21582.
PMID: 16323194
Diagnosis
Tilleul P,
Brignone M,
Hassani Y,
Labrande C,
Pedeboscq S,
Gensollen S,
Lahille B,
Exinger D,
Bertholle V,
Billard M,
Charlety D,
Prebay D,
Pinguet F,
Taillibert S,
Cartalat S,
Chinot O,
Borget I;
Temozolomide Study Group of Société Française de Pharmacie Oncologique
Pharmacoepidemiol Drug Saf
2012 Aug;21(8):828-34.
Epub 2012 Mar 15
doi: 10.1002/pds.3233.
PMID: 22419509
Kizilarslanoglu MC,
Aksoy S,
Yildirim NO,
Ararat E,
Sahin I,
Altundag K
J BUON
2011 Jul-Sep;16(3):547-50.
PMID: 22006764
Therapy
Kizilarslanoglu MC,
Aksoy S,
Yildirim NO,
Ararat E,
Sahin I,
Altundag K
J BUON
2011 Jul-Sep;16(3):547-50.
PMID: 22006764
Hau P,
Jachimczak P,
Bogdahn U
Expert Rev Anticancer Ther
2009 Nov;9(11):1663-74.
doi: 10.1586/era.09.138.
PMID: 19895249
Trinh VA,
Patel SP,
Hwu WJ
Expert Opin Drug Saf
2009 Jul;8(4):493-9.
doi: 10.1517/14740330902918281.
PMID: 19435405
Koukourakis GV,
Kouloulias V,
Zacharias G,
Papadimitriou C,
Pantelakos P,
Maravelis G,
Fotineas A,
Beli I,
Chaldeopoulos D,
Kouvaris J
Molecules
2009 Apr 16;14(4):1561-77.
doi: 10.3390/molecules14041561.
PMID: 19384285Free PMC Article
Friedman HS,
Kerby T,
Calvert H
Clin Cancer Res
2000 Jul;6(7):2585-97.
PMID: 10914698
Prognosis
Koukourakis GV,
Kouloulias V,
Zacharias G,
Papadimitriou C,
Pantelakos P,
Maravelis G,
Fotineas A,
Beli I,
Chaldeopoulos D,
Kouvaris J
Molecules
2009 Apr 16;14(4):1561-77.
doi: 10.3390/molecules14041561.
PMID: 19384285Free PMC Article
Chamberlain MC,
Johnston S
J Neurooncol
2009 Feb;91(3):359-67.
Epub 2008 Oct 25
doi: 10.1007/s11060-008-9722-2.
PMID: 18953491
Friedman HS,
Kerby T,
Calvert H
Clin Cancer Res
2000 Jul;6(7):2585-97.
PMID: 10914698
Clinical prediction guides
Tilleul P,
Brignone M,
Hassani Y,
Labrande C,
Pedeboscq S,
Gensollen S,
Lahille B,
Exinger D,
Bertholle V,
Billard M,
Charlety D,
Prebay D,
Pinguet F,
Taillibert S,
Cartalat S,
Chinot O,
Borget I;
Temozolomide Study Group of Société Française de Pharmacie Oncologique
Pharmacoepidemiol Drug Saf
2012 Aug;21(8):828-34.
Epub 2012 Mar 15
doi: 10.1002/pds.3233.
PMID: 22419509
Trinh VA,
Patel SP,
Hwu WJ
Expert Opin Drug Saf
2009 Jul;8(4):493-9.
doi: 10.1517/14740330902918281.
PMID: 19435405
Koukourakis GV,
Kouloulias V,
Zacharias G,
Papadimitriou C,
Pantelakos P,
Maravelis G,
Fotineas A,
Beli I,
Chaldeopoulos D,
Kouvaris J
Molecules
2009 Apr 16;14(4):1561-77.
doi: 10.3390/molecules14041561.
PMID: 19384285Free PMC Article
Friedman HS,
Kerby T,
Calvert H
Clin Cancer Res
2000 Jul;6(7):2585-97.
PMID: 10914698
Mittelman A,
Chun HG,
Puccio C,
Coombe N,
Lansen T,
Ahmed T
Invest New Drugs
1999;17(2):179-82.
doi: 10.1023/a:1006379402114.
PMID: 10638489